相关实验视频

Updated: Jun 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

图像引导向癌症免疫治疗的模板导向的RIG-I激素组合

Subrata K Ghosh¹, Douglas Lazarus², Neil Robertson¹

¹TransCode Therapeutics, Inc., 400 Trade Center, Suite 5900, Woburn, MA, 01801, USA.

Molecular imaging and biology

|February 19, 2026

概括

这项研究开发了一种用于RIG-I激动剂的新型纳米粒子递送系统,使得向瘤细胞亡和免疫反应诱导成为可能. 这一策略对图像导向的癌症免疫疗法充满希望.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米技术纳米技术
分子生物学分子生物学

背景情况:

瘤特异性免疫疗法提供有针对性的癌症治疗,毒性降低.
像RIG-I这样的模式识别受体可以诱导抗瘤反应,但面临着交付和目标之外的挑战.
目前的局限性阻碍了基于RIG-I的免疫疗法的临床转化.

研究的目的:

在瘤特异性RNA模板上开发RIG-I激动剂细胞内组合的策略.
为了克服输送问题和RIG-I激动剂在癌症治疗中的脱效应.
使用超偏磁纳米粒子载体进行向传递和图像导向治疗.

主要方法:

一个单链抗miR-21 5'-三酸盐RIG-I激动剂的结合,使其与德克斯涂层纳米粒子 (TTX) 相结合.
在B16-F10黑色素瘤小鼠模型中的体外和体外测试.
磁共振成像 (MRI) 用于可视化纳米粒子输送和治疗疗效评估.

主要成果:

在黑色素瘤细胞中证明了miRNA-21依赖的RIG-I信号传递和亡.
在动物模型中抑制瘤生长并诱导针对瘤复发的免疫力.
证实了纳米粒子系统启动特定RIG-I信号的能力.

结论:

模板驱动的方法促进了瘤细胞内的RIG-I激活.
通过纳米颗粒系统输送RIG-I激动剂可以增强抗瘤免疫反应.
这一战略推进了RIG-I作为瘤学中临床相关的目标.

关键词:

图像指导疗法是指导图像的疗法.免疫疗法是一种免疫疗法.提供橄核酸的输送.在RIG-I信号中,RIG-I正在发送信号.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.